Citius Pharmaceuticals Inc (NASDAQ:CTXR)
| 0.6975 Delayed Data As of Sep 28 |  +0.006 / +0.87%Today’s Change | 0.63 Today|||52-Week Range 1.71 | -11.71% Year-to-Date |
Latest CTXR News | Press Releases
No recent news for Citius Pharmaceuticals Inc.
Today’s Trading
| Previous close | 0.69 |
| Today’s open | 0.69 |
| Day’s range | 0.68 - 0.70 |
| Volume | 1,516 |
| Average volume (3 months) | 1,347,615 |
| Market cap | $111.7M |
Data as of 3:59pm ET, 09/28/2023
Growth & Valuation
| Earnings growth (last year) | -2.08% |
| Earnings growth (this year) | +10.14% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.00 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GRTSGritstone bio Inc | +0.37 | +31.09% |
| ---- | ||
| PRQRProQR Therapeutics N... | -0.05 | -3.62% |
| ESPREsperion Therapeutic... | -0.03 | -2.81% |
Data as of 4:00pm ET, 09/28/2023
Financials
| Next reporting date | December 13, 2023 |
| EPS forecast (this quarter) | -$0.05 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$33.6M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Cranford, New Jersey |
Forecasts
